65% of U.S. doctors reportedly use OpenEvidence, which is supported in part by pharmaceutical ads.

OpenEvidence chief Daniel Nadler says he envisions changing the company’s ad-supported model, which has kept it free for medical professionals and driven its widespread adoption.

OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly two-thirds of physicians.

Exclusive: Doctors say ‘highly concerning’ poll highlights risk to patients of turning to AI for medical advice

65% of U.S. doctors reportedly use OpenEvidence, which is supported in part by pharmaceutical ads.